Oxolamine
Zyntex supplies high-purity Oxolamine, a unique 1,2,4-oxadiazole derivative. It is a critical active pharmaceutical ingredient (API) known for its dual action as a peripherally acting antitussive and a potent respiratory anti-inflammatory agent.
Description
Therapeutic Benefits of Oxolamine
In the treatment of acute and chronic respiratory conditions, this specialized 1,2,4-oxadiazole derivative offers unique functional advantages due to its ability to reduce the sensitivity of bronchial stretch receptors. Many pharmaceutical formulators prefer Oxolamine because it provides targeted relief from non-productive coughs while simultaneously addressing the underlying inflammation of the respiratory mucosa. Moreover, the compound exhibits a favorable safety profile as it does not suppress the respiratory center in the brain. Therefore, the active ingredient remains a cornerstone for treating tracheitis, pharyngitis, and acute bronchitis. Zyntex delivers this product with high assay levels to ensure it integrates seamlessly into your liquid dosage forms and pharmaceutical synthesis processes.
Key Oxolamine Applications
This versatile respiratory active delivers superior results across these four key clinical and technical areas:
🗣️ Cough Suppression
It acts as a primary active ingredient in syrups for the relief of dry, irritating coughs by desensitizing bronchial receptors.
🫁 Anti-inflammatory
Effectively reduces mucosal edema and localized inflammation in both upper and lower respiratory tracts.
🔬 Clinical Research
Utilized as a pharmacological tool to investigate peripheral cough mechanisms and cytokine modulation in lung tissue.
💊 API Intermediate
Serves as a critical pharmaceutical building block for the synthesis of advanced medicinal oxadiazole derivatives.
Technical Specifications
| Parameter | Specification Standard |
|---|---|
| Product Name | Oxolamine |
| CAS Number | 959-14-8 |
| Molecular Formula | C14H19N3O |
| Assay (Purity) | Min. 98.0% |
